BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16436125)

  • 1. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].
    Jabłonowska E; Kuydowicz J; Małolepsza E
    Przegl Epidemiol; 2008; 62(3):605-12. PubMed ID: 19108525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
    Jimenez HR; Hallit RR; Debari VA; Slim J
    Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents.
    Siberry GK; Coller RJ; Henkle E; Kiefner C; Joyner M; Rogers J; Chang J; Hutton N
    Pediatr Infect Dis J; 2008 May; 27(5):465-8. PubMed ID: 18382387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to hepatitis A virus vaccination in HIV-infected men who have sex with men.
    Kourkounti S; Paparizos V; Leuow K; Paparizou E; Antoniou C
    Int J STD AIDS; 2015 Oct; 26(12):852-6. PubMed ID: 25411352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation.
    Jabłonowska E; Kuydowicz J
    Int J STD AIDS; 2014 Sep; 25(10):745-50. PubMed ID: 24452731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.
    Tedaldi EM; Baker RK; Moorman AC; Wood KC; Fuhrer J; McCabe RE; Holmberg SD;
    Clin Infect Dis; 2004 May; 38(10):1478-84. PubMed ID: 15156488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
    Laurence JC
    Am J Med; 2005 Oct; 118 Suppl 10A():75S-83S. PubMed ID: 16271546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to hepatitis A vaccination in HIV-infected men in Greece.
    Kourkounti S; Mavrianou N; Paparizos VA; Kyriakis K; Hatzivassiliou M; Kordosis T; Katsambas A
    Int J STD AIDS; 2012 Jul; 23(7):464-7. PubMed ID: 22843998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination.
    Sun HY; Kung HC; Ho YC; Chien YF; Chen MY; Sheng WH; Hsieh SM; Wu CH; Liu WC; Hung CC; Chang SC
    Int J Infect Dis; 2009 Sep; 13(5):e199-205. PubMed ID: 19208490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
    Wallace MR; Brandt CJ; Earhart KC; Kuter BJ; Grosso AD; Lakkis H; Tasker SA
    Clin Infect Dis; 2004 Oct; 39(8):1207-13. PubMed ID: 15486846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.